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Background: The New Forest Parenting Programme (NFPP) is a home-delivered, evidence-based parenting
programme to target symptoms of attention-deficit/hyperactivity disorder (ADHD) in preschool children. It has been
adapted for use with ‘hard-to-reach’ or ‘difficult-to-treat’ children. This trial will compare the adapted-NFPP with a
generic parenting group-based programme, Incredible Years (IY), which has been recommended for children with
preschool-type ADHD symptoms.
Methods/design: This multicentre randomized controlled trial comprises three arms: adapted-NFPP, IY and
treatment as usual (TAU). A sample of 329 parents of preschool-aged children with a research diagnosis of ADHD
enriched for hard-to-reach and potentially treatment-resistant children will be allocated to the arms in the ratio
3:3:1. Participants in the adapted-NFPP and IY arms receive an induction visit followed by 12 weekly parenting
sessions of 1½ hours (adapted-NFPP) or 2½ hours (IY) over 2.5 years. Adapted-NFPP will be delivered as a
one-to-one home-based intervention; IY, as a group-based intervention. TAU participants are offered a parenting
programme at the end of the study. The primary objective is to test whether the adapted-NFPP produces beneficial
effects in terms of core ADHD symptoms. Secondary objectives include examination of the treatment impact on
secondary outcomes, a study of cost-effectiveness and examination of the mediating role of treatment-induced
changes in parenting behaviour and neuropsychological function. The primary outcome is change in ADHD symptoms,
as measured by the parent-completed version of the SNAP-IV questionnaire, adjusted for pretreatment SNAP-IV score.
Secondary outcome measures are: a validated index of behaviour during child’s solo play; teacher-reported SNAP-IV
(ADHD scale); teacher and parent SNAP-IV (ODD) Scale; Eyberg Child Behaviour Inventory - Oppositional Defiant
Disorder scale; Revised Client Service Receipt Inventory - Health Economics Costs measure and EuroQol (EQ5D)
health-related quality-of-life measure. Follow-up measures will be collected 6 months after treatment for participants
allocated to adapted-NFPP and IY.
Discussion: This trial will provide evidence as to whether the adapted-NFPP is more effective and cost-effective than
the recommended treatment and TAU. It will also provide information about mediating factors (improved parenting
and neuropsychological function) and moderating factors (parent and child genetic factors) in any increased benefit.
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Estimates of the prevalence of attention-deficit/hyper-
activity disorder (ADHD) vary widely within and be-
tween countries. The UK National Institute for Health
and Care Excellence (NICE) have estimated that around
5% of school-aged children and adolescents meet the
DSM-IV diagnostic criteria for ADHD, equivalent to
366,000 children and adolescents in England and Wales
[1]. Attention-deficit/hyperactivity disorder is a debili-
tating mental health disorder, which is marked by symp-
toms of inattention, overactivity and impulsiveness that
have an early onset, and are age inappropriate, persistent
and pervasive [2]. It affects children over their school
years and into adulthood [3] and is associated with a num-
ber of impairments that impinge on a range of social and
health care systems (education, criminal justice, mental
health, social services, and so on) [4]. Those with ADHD
are at increased risk of delinquency, criminality, educa-
tional failure and mental illness [5,6]. Treatment for
ADHD typically begins during the middle school years [2]
and multimodal approaches are recommended [7]. Stimu-
lant and nonstimulant [7,8] medications are considered
the most efficacious treatments and are recommended.
However, these have a number of limitations [9-12], in-
cluding reported side effects [11,13,14] and can give rise
to parental concerns about the use of medication for
behavioural control [15]. Furthermore, medication on its
own might not improve other outcomes, such as social
and academic functioning [16]. Nonpharmacological treat-
ments, such as classroom-based behaviour modification
or parent-training programmes can also be valuable but
appear not to provide the same control of ADHD symp-
toms offered by pharmacological treatments [17].
To optimize the effects of nonpharmacological therap-
ies, early intervention approaches implemented during
the preschool period have been proposed [18]. Such pro-
posals are consistent with the fact that, even though most
ADHD cases are first formally diagnosed and treated in
middle childhood, ADHD often has its roots in the pre-
school period [19-21]. In fact, while significant levels of
preschool-type ADHD symptoms may not always signal
the early ‘onset’ of impairment, numbers of referrals of
ADHD before the age of 5 years are growing [1,5,22].
A number of parent-training programmes have been
developed to target preschool ADHD [23-25]. The New
Forest Parenting Programme (NFPP) is a home-based
approach designed specifically to target the core symp-
toms of ADHD in preschool children. It is delivered on
a one-to-one basis [26]. It has been shown in randomized
controlled trials (RCTs) to substantially reduce levels of
ADHD symptoms and related problems, such as oppos-
itional defiant disorder (ODD) [27,28]. A second approach,
the Incredible Years (IY) programme, was originally de-
signed to target children’s oppositional and noncompliantbehaviour. It consists of a suite of programmes for parents,
children and teachers. While originally, and still mainly,
delivered to groups of parents, children and teachers,
there is now also a home-coaching model for the parent
programme. These programmes, both individual and in
various combinations, have been demonstrated to re-
duce children’s noncompliance and troublesome behav-
iour and increase positive behaviour [29]. It has also
produced generally positive effects on these outcomes
with preschool children, including those with or at risk
of ADHD [29-32]. A recent adaptation specifically for
children with ADHD has shown benefits in terms of
parents’ ratings of ADHD symptom reduction [33-37].
The IY programme has been recommended for use with
preschool ADHD children in influential guidelines, such
as those published by NICE [38], partly on the basis that
its group-based nature is thought to be a cost-effective
therapy [39].
Despite positive findings from RCTs, there are many
barriers to effective implementation of these treatments
in everyday practice [40-42], especially with regard to in-
dividuals and families traditionally seen as hard to en-
gage and treat. Such factors as the presence of parental
mental health problems, the existence of additional child
comorbid conditions, cognitive and language problems
and the presence of adverse environmental factors need
to be addressed if preschool parenting packages are likely
to work with those most in need of help. Knowing how to
access and engage ‘at-risk’ and ‘hard-to-reach’ children
and their families, who may be living in difficult circum-
stances, is therefore central to the development of an ef-
fective early detection and intervention strategy. Previous
research indicates that when access is made available,
the outcomes for ‘hard-to-reach’ families attending the
IY parent programme are as good as those less disad-
vantaged [43].
The Comparison of Preschool Parenting Interventions
(COPPI) trial is the fifth and final project in the 5-year
Programme for Early Detection and Intervention for
ADHD (PEDIA). This programme of research, funded
by the National Institute for Health Research, is being
carried out at the University of Southampton in collab-
oration with Solent NHS Trust, and at two other cen-
tres: the University of Nottingham in collaboration with
Nottingham City Care and Nottingham County Health
Partnerships and the North Staffordshire Combined
Healthcare NHS Trust.
Using an evidence-driven approach, the NFPP has
been recently adapted to address the specific needs of
‘hard-to-reach’ and ‘difficult-to-treat’ preschool children
with ADHD and their families (F McEwan et al., unpub-
lished work) [44]. This has involved extending it from
an 8- to a 12-week programme with the inclusion of
specific modules to address such problems as parental
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mental conditions. In this trial, we will evaluate the ef-
fectiveness and cost-effectiveness of the adapted-NFPP
against IY and treatment as usual (TAU) in a multicen-
tre RCT.
Aims and objectives
The overall aim of this study is to conduct a large-scale
multicentre RCT of the efficacy of the adapted-NFPP by
comparing it with (i) a TAU group and (ii) a generic par-
enting package recommended by NICE (IY) in a sample
enriched for potentially hard-to-reach and treat children.
The key objectives are to test whether, for individuals
with preschool-type ADHD problems, the adapted-NFPP
produces statistically greater beneficial effects in terms of
core symptoms of ADHD and other secondary outcomes
(general child behaviour problems and parental mental
health); to determine whether outcomes are moderated by
factors that might be predictive of long-term burden and
other potentially important moderators, including genetic
factors; to determine whether effects are mediated by (a)
improved parenting and (b) improved neuropsychological
function; and to determine whether the adapted-NFPP is
more cost-effective.
The main research questions are:
1. Does the adapted-NFPP produce statistically greater
reductions in ADHD symptoms compared with a
TAU group and standard IY 12-week parenting
programme in a sample of individuals with
preschool-type ADHD problems enriched for
‘hard-to-reach’ and potentially treatment-resistant
preschool children?
2. Do these effects extend to other problems, such as
child conduct problems?
3. Do they generalize from home to educational
settings?
4. Are these effects moderated by (i) factors that might
be predictive of long-term burden as well as other
putative barriers to treatment efficacy and (ii)
genetic factors?
5. Are these effects mediated by (a) improved parenting
and (b) improved neuropsychological function?
6. Do benefits persist in the longer term (for example,
6 months after treatment)?
7. Is the adapted-NFPP cost-effective relative to IY in
this enriched sample over a 6-month period and
does the added value of adapted-NFPP outweigh any
additional costs of treatment delivery?
Methods/design
Trial design
A multicentre three-arm RCT will be carried out to evalu-
ate the efficacy and cost-effectiveness of adapted-NFPPcompared with IY and TAU for preschool children with a
research diagnosis of ADHD in a sample enriched to en-
sure a high percentage of potentially high-burden and
difficult-to-treat cases. Participants will be randomly al-
located to adapted-NFPP, IY and TAU in the ratio 3:3:1.
Randomization will be stratified by participating centre
and tranche.
Study setting
Participants will be enlisted at the three centres participat-
ing in the trial: the University of Southampton and Solent
NHS Trust; the North Staffordshire Combined Health
Care NHS Trust; and the University of Nottingham and
Nottingham City Care and Nottinghamshire County
Health Partnerships. All centres will run the trial in
accordance with good clinical practice guidelines and
will work in collaboration with National Institute for
Health Research (NIHR) local research networks and
with the University of Southampton Clinical Trials Unit
(UoSCTU).
Eligibility criteria
Inclusion criteria
Inclusion criteria are: (1) Parents or main caregivers
aged 18 years or older (with or without moderate mental
health issues); (2) Child aged between 2 years 9 months
and 4 years 6 months with significant ADHD-type behav-
iour (with or without comorbid conditions, such as lan-
guage and communication difficulties, learning difficulties
or behaviour problems); (3) positive screening for ADHD
symptoms (score ≥20) based on the parent-reported
Werry-Weiss-Peters Activity Rating Scale [45] followed by
a score above clinical thresholds on the parent-reported
Diagnostic Interview Schedule for Children Version 4
(DISC-IV) ADHD Scale [46]; that is, six or more symp-
toms on either the inattention subscale or the hyper-
active/impulsivity subscale, or combined, but in either
case with a rating of impact or impairment.
Exclusion criteria
Child exclusion criteria are: (i) diagnosis of autism; (ii) be-
ing in foster care without a long-term plan in that foster
placement; (iii) extreme learning difficulties, as defined by
a score below an age-appropriate developmental level for
more than 6 out of 12 items taken from four scales of the
Parent Involvement Project (PIP) Developmental Scales
[47] including: physical development, three items; devel-
opment, four items; eye-hand co-ordination development,
one item; development of play, four items; (iv) very poor
or no language as defined by a score below an age-
appropriate developmental level for more than three out
of six items taken from the Language Development Scale
of the PIP Developmental Scales [47]. Parent exclusion
criteria are: (v) no working knowledge of English; (vi)
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learning difficulties, manic depressive disorder); (vii) hav-
ing a child on the Child Protection Register.
Interventions
Arm A: Adapted-NFPP
The original 8-week individually delivered home-based
NFPP was developed as a specialized psychological inter-
vention for preschool children and focuses on reducing
the core symptoms of ADHD [48]. The value of early
intervention is demonstrated in three NFPP trials [26-28],
which have shown it to be effective in reducing ADHD
symptoms and conduct problems. Short-term effects on
parental mental health and the quality of mother-child in-
teractions were also observed [26,27]. This programme in-
cludes components of psychoeducation of parents about
ADHD and teaches strategies of proactive parenting in the
context of a child with ADHD. It aims to enhance the
mother-child relationship through play. It also includes an
attention and organizational training component to target
the underlying neuropsychological basis of the condition
(for example, poor concentration and working memory
and inability to cope with delay) using games played to-
gether by the preschool ADHD child and the child’s
mother. The original trial of this programme in a RCT
had an effect size of 0.87 for ADHD symptoms [27], while
a recent smaller RCT had an effect size of 1.96 [26]. The
adapted-NFPP is based on the original NFPP but modified
to be potentially more effective with treatment-resistant
and hard-to-reach families and children on the basis of
qualitative research [49] and piloting carried out prior to
the start of the current trial (F McEwan et al., unpublished
work). The 12-week programme provides the time to de-
liver the original 8-week programme at a slower pace.
Additional modules are included to address (a) the child’s
sleep problems, learning difficulties and speech and lan-
guage problems and (b) parental mental health problems,
learning difficulties and ADHD. A component on mind-
fulness for parents has also been added, as has training in
motivational techniques and the use of social stories. The
adapted-NFPP will be carried out in weekly sessions of ap-
proximately 1.5 hours’ duration over a 12-week period.
Course materials provided during the course of the
programme include handouts, a DVD (adapted for pre-
school children), an audio CD and other resources (see
Appendix 1).
Arm B: Incredible Years
The IY programme is a series of programmes for par-
ents, children and teachers and includes a suite of par-
enting programmes focused on strengthening parenting
competencies (monitoring, positive discipline, confidence)
and fostering the parent–child relationship, as well as
targeting involvement in children’s school experiences, inorder to promote academic, social and emotional compe-
tencies and reduce conduct problems. The IY parenting
programmes [50], as recommended by NICE [38], have
been developed to help parents prevent or manage oppos-
itional and challenging behaviour through the use of
reinforcement and have been shown to be effective in im-
proving parenting skills, reducing conduct problems and
improving parent–child relationships [29,35,51]. A modi-
fied version of the IY being used in the current trial has
also shown some value in the treatment of preschool
children displaying early signs of ADHD [33,36,37]. The
parenting programmes are recommended by the Ameri-
can Psychological Association Task Force as meeting ac-
cepted criteria for empirically supported mental health
intervention for children with conduct problems. They
are also one of the few programmes identified in the
University of Colorado Blueprint classification of pro-
grammes with good evidence for violence prevention
[52]. The techniques used to help parents acquire new
skills are facilitator-led group discussion, brainstorming,
videotape modelling, role play and rehearsal of the taught
intervention techniques within groups and through home-
work. A number of skills are taught in weekly sessions,
usually over a period of 12 weeks or more. Parents are
shown how to use: (i) play and child-centred activities to
promote a positive relationship with their child; (ii) praise,
reward and incentive to promote appropriate child behav-
iours; (iii) effective limit setting and clear instruction; and
(iv) the use of strategies to manage noncompliant behav-
iour. Course materials include handouts, CDs, books
and prizes, which are awarded during the course of the
programme. Parents who miss a session receive weekly
calls and also, where possible, visits from a therapist to en-
courage the parent and to monitor progress. This is an 8-
part programme, with each part building on the previous
one, and is designed to support parents by strengthening
positive and nurturing parenting skills (see Appendix 2). It
is carried out in weekly sessions of approximately 2 to
2.5 hours’ duration over a 12-week period.
Arm C: TAU
For those parents randomized to the TAU group, measures
will be collected before and after the 12-week programme.
Measures will not be collected from the TAU group
6 months after treatment, as with the adapted-NFPP and
IY participants. After final data collection, parents in
the TAU group will be offered individual home-based
treatment with adapted-NFPP or a place in an IY group-
based programme.
Programme fidelity
Strategies for ensuring fidelity are incorporated as inte-
gral parts of the two parenting programmes, including
training and monitoring procedures. In addition, a common
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as required by each programme, so that these factors can
be compared across treatments and their effects on out-
come assessed. Procedures for optimizing fidelity relate
to the selection, training and supervision of therapists
and the skills to be acquired by therapists. The thera-
pists for both programmes come mostly from a health
background and are nurses with a background in child
and adult mental health services (CAMHS), paediatrics
or health visiting; psychologists with a background in
CAMHS or behavioural management; family support
workers with a background in CAMHS; or senior social
workers with experience in children services. As initial
training, therapists delivering both programmes will at-
tend a residential training course focused on the tech-
niques necessary to deliver the programme. The basic
3-day IY parent group leader workshop teaches leaders
how to use the programme as preventive early interven-
tion in a range of settings. Attending this workshop is
the first step in becoming a certified group leader.
Training covers three parent programmes, for parents
of toddlers aged 1 to 3 years, parents of preschool chil-
dren aged 3 to 6 years and parents of school-aged chil-
dren 6 to 8 years old. Both sets of therapists will have
ongoing supervision both locally and centrally through-
out the time of the trial using face-to-face supervision,
by telephone and monitoring of videotaped sessions re-
cording their work with families. Training and supervision
of IY therapists and leaders is overseen by practitioners
with extensive experience of delivering IY and a clinician
(JH) with extensive experience in working with the IY set
of programmes and their development. Training and
supervision of adapted-NFPP therapists is overseen by a
clinician (MT) and a consultant nurse specializing in
ADHD (CLB), both with extensive experience in conduct-
ing the NFPP and its development.
Fidelity measures
Session checklists and evaluation forms will be completed
by therapists. Three instruments will also be used to
monitor process and treatment fidelity across both pro-
grammes and their moderating effects on outcomes.
Process fidelity will be measured using a modified version
of the Leader Observation Tool (LOT) after treatment is
finished [53]. The Working Alliance Inventory [54] will be
used to look at aspects of the parent-therapist relationship
during therapy. The impact of treatment on the family will
be measured using the Family Strain Index [55].
Study measures
Screen and diagnostic interview
Three measures will be administered to determine the
eligibility of parents and their children for inclusion in
the study: the Werry-Weiss-Peters Activity Rating Scale(WWP) [45]; the DISC-IV ADHD Scale [46] and the PIP
Developmental Scale [47]. Scores on the WWP will de-
termine whether the child has ADHD symptoms at a
significant level of severity to proceed with the adminis-
tration of the DISC-IV-Parent preschool ADHD diag-
nostic interview. Items on the PIP Developmental Scale
will indicate the presence of poor or no language and se-
vere child learning disability or poor development.
Primary and secondary measures
The primary outcome measure is the SNAP-IV-P ADHD
Scale (parent-completed), which will be collected at the
three time points and records the frequency of occurrence
of ADHD symptoms [56]. Secondary outcome measures
include a child observation measure carried out by the re-
search fellow using the Child’s Solo Play Index [27]; the
teacher-completed SNAP-IV-T ADHD Scale; the teacher
and parent-completed SNAP-IV ODD scale [56] and the
Eyberg Child Behaviour Inventory [57], both of which are
measures of noncompliant and oppositional behaviour
Economic costing
Economic measures include the Revised Client Service
Receipt Inventory (R-CSRI) [58] and the parent-reported
EQ(5D) and proxy-parent-reported child measure [59].
Mediators
Factors that might play a mediating role in the effectiveness
of the parenting programmes will be investigated and will
be collected at all time points. Measures employed will in-
clude the expressed emotion five-minute speech sample
(FMSS) [60]; the Global Impressions of Parent–child In-
teractions (GIPCI) observation measures, which include
‘Jigsaw’, ‘Tidy-up’ and ‘Free play’ [61,62]; the ‘Cookie
delay’ task, which is a measure of inhibition [63], and
the parent-completed General Health Questionnaire [64].
Moderators
Factors that might play a moderating role include the
Current Symptoms Scale [65], which is a measure of par-
ental ADHD symptoms. Saliva samples will also be col-
lected to investigate parent and child gene polymorphisms
related to the ADHD phenotype including DRD4, DRD2,
5HTT-LPR, COMT, MAO-A and OR-A and their impact
on the effectiveness of the parenting programme.
The possible role of the PARI (Preschool ADHD Risk
Index) in moderating the effectiveness of the parenting
programmes will also be examined. As part of the overall
5-year PEDIA programme of research, the PARI will be
developed based on the outcomes of a longitudinal study
of adult outcomes of preschool hyperactivity. A range of
child behavioural and developmental factors will be consid-
ered, together with a range of maternal and demographic
factors. A demographic questionnaire will be administered
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characterize the sample. The parent-completed Current
Symptom Scale, a parental ADHD symptom measure,
and the Emotionality, Activity, Sociability and Impulsiv-
ity (EASI) questionnaire, a measure of child tempera-
ment, will also be administered at baseline only and
used for the purposes of the PARI analysis, if these fac-
tors are found to contribute to high risk and burden in
the ongoing longitudinal study.
A more detailed description of all study instruments is
included in the section on data collection methods.
Participant timelines
Outcome measures are collected at pretreatment (T1),
post-treatment (T2) and, in the case of those participants
allocated to Arm A or Arm B, also at 6 months post-
treatment (T3). A time schedule of enrolment, interven-
tions and measures is presented in Table 1.
Sample size
The trial is powered for two comparisons of interest.
Primary question: adapted-NFPP versus Incredible Years
(Arm A vs Arm B).
Is adapted-NFPP superior to IY in terms of reductions
in parent-rated ADHD symptoms? Assuming a conser-
vative estimate of effect size difference of 0.4 standard
deviation between adapted-NFPP and IY, an intraclass
correlation of 0.08 for parents treated in the same IY
groups and a drop-out rate of 10% (considerably higher
than in the original trials) it is estimated that 141 indi-
viduals will be needed per treatment arm to provide suf-
ficient power to test the hypothesis that the adapted-
NFPP is superior to IY in terms of reduction in ADHD
symptoms (total N = 282). This equates to a difference of
mean 0.28 and standard deviation 0.7 on the SNAP-IV-P
ADHD rating scale (the primary outcome) using a 5%
two-tailed test of significance and 80% power. A design
effect of 1.28 has been calculated from the formula:
1þ m−1ð Þp
in the CONSORT (Consolidated Standards of Report-
ing Trials) statement for nonpharmacological interven-
tions [66].
Secondary question: adapted-NFPP versus treatment
as usual (Arm A vs Arm C).
Is the adapted-NFPP superior to TAU in terms of re-
ductions in parent-rated ADHD symptoms? Again as-
suming a conservative estimate of effect size difference
between adapted-NFPP vs TAU, a group of 141 adapted-
NFPP and 47 TAU will give 81% power to detect an effect
size of 0.5 on the SNAP-IV-P ADHD score (equating to a
difference of mean 0.35 and standard deviation 0.7) with
5% two-tailed significance. No intraclass correlation hasbeen applied for this calculation, as both adapted-NFPP
and TAU will be delivered individually.
On this basis, each of the three centres will recruit ap-
proximately 110 families with a preschool-aged child
(age 2 years 9 months to 4 years 6 months) with high
levels of ADHD symptoms (total n = 329) into the trial.
Families will be randomized with intention to treat to ei-
ther (i) adapted-NFPP as an individually delivered, home-
based parenting programme (n =141, leaving 127 for final
analysis with 10% drop-out); (ii) IY delivered in groups of
eight (n = 141, leaving 127 for final analysis with 10%
drop-out); or (iii) TAU (n = 47, leaving 42 for the final ana-
lysis with 10% drop-out).
Recruitment
The plan for recruitment takes into account that (a) two
research fellows will be available at each centre to con-
duct screening and the diagnostic interview, recruit par-
ticipants to the study and complete T1 to T3 visits for
each tranche and (b) two pairs of therapists will be
employed at each centre to cover the two parenting pro-
grammes. Given a target recruitment of n = 329 partici-
pants (110 participants per centre) and factoring in
school holiday periods, it is estimated that five or six
parenting programme tranches will be needed, with 18
to 22 parents enlisted per tranche across centres. An allo-
cation ratio of 3:3:1 will mean that approximately eight
parents will be allocated to each pair of therapists. Two
NFPP therapists will each work on a one-to-one basis with
four parents over the 12-week period of the programme
and two IY therapists or leaders will conduct a group-
based programme in a local hall with eight parents, whose
partners may also attend the group.
The collaboration of local agencies and services acting
as participant identification centres across each of the
sites will be sought to help achieve recruitment targets
for each tranche of parenting programmes. Practitioners
and clinicians across agencies will make study enlistment
packs available to parents. These packs contain a letter
to the parent, an information sheet, an expression of
interest form, a consent to screen form and a freepost
envelope for the return of the expression of interest and
consent forms to the research office. Posters, radio adver-
tisements and social media will also be used to recruit a
broad range of parents to the study. For the purpose of
ensuring sufficient numbers of hard-to-reach and poten-
tially difficult-to-treat families, the sample will be enriched
by targeting a range of different referral sources and using
previously developed outreach strategies to increase en-
gagement of these families. Multiple recruitment routes
will be used at each of the centres participating in the trial;
these will include health visiting and Sure Start profes-
sionals; speech and language clinics; community paediatric
clinics; and CAMHS. To determine the proportion of
Table 1 Enrolment, interventions and assessments
Contact and home visits Screening or
diagnostic
interview
Consent
and TENALEA
allocation
Pretreatment
(T1) visit
Induction
visit by
therapist
Intervention:
a-NFPP (home)
IY (local hall)
Post-treatment
(T2) visit (TAU =
end of study)
6 month follow-up
(T3) visit (a-NFPP/
IY = end of study)
Timeline Week 1 to Week 10 Week 11
to 12
Week 13 to 24 Week 25 to 28 Week 50
Enrolment
Participant informed consent ✓ ✓
Eligibility
WWP (child hyperactivity);
parent-completed scale
✓
PIP developmental scales;
research-fellow-administered
scale
✓
DISC-IV ADHD scale, child;
research-fellow-administered
interview
✓
TENALEA allocation ✓
Interventions
Arm A: a-NFPP ✓ ✓ ✓ ✓ ✓ ✓ ✓
Arm B: IY ✓ ✓ ✓ ✓ ✓ ✓ ✓
Arm C: TAU ✓ ✓ ✓ ✓
Measures
Primary outcome
SNAP IV-P ADHD scale;
parent-completed
questionnaire
✓ ✓ ✓
Secondary outcomes ✓ ✓ ✓
Child’s solo play; observation
measure, research-fellow-
completed
✓ ✓ ✓
SNAP IV-T ADHD scale;
teacher-completed
questionnaire
✓ ✓ ✓
SNAP IV-P and T ODD scale:
parent- and teacher-
completed questionnaires
✓ ✓ ✓
ECBI (ODD measure); parent-
completed questionnaire
✓ ✓ ✓
CSRI-Revised (economic
costs); research-fellow-
administered questionnaire
✓ ✓ ✓
EQ-5D QOL: Parent and
parent proxy;parent-
completed questionnaires
✓ ✓ ✓
Mediators
FMSS (maternal expressed
emotion); research-fellow-
rated
✓ ✓ ✓
GIPCI, child/parent
observation measure;
research-fellow-rated
✓ ✓ ✓
Cookie delay task, child
observation measure;
research-fellow-rated
✓ ✓ ✓
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Table 1 Enrolment, interventions and assessments (Continued)
GHQ - maternal; parent-
completed questionnaire
✓ ✓ ✓
Moderators
CSS (parental ADHD); parent-
completed questionnaire
✓
Preschool ADHD Risk Index;
research-fellow-scored index
✓
EASI (child temperament);
parent-completed
questionnaire
✓
Demographic questionnaire;
parent-completed
questionnaire
✓
Genetic testing (saliva
sample); self-collected, parent
& child
✓ ✓
LOT; research-fellow-rated ✓
WAI-S; parent- and therapist-
completed questionnaires
✓ ✓
FSI; parent- and therapist-
rated
✓ ✓
a-NFPP: adapted New Forest Parenting Programme; CSRI-R: Revised Client Service Receipt Inventory; CSS, Current Symptoms Scale; DISC-IV, Diagnostic Interview
Schedule for Children Version 4; EASI, Emotionality, Activity, Sociability and Impulsivity; EE, expressed emotion; ECBI, Eyberg Child Behaviour Inventory; EQ-5D,
EuroQol - 5 Dimensions; FMSS, five-minute speech sample; FSI, Family Strain Index; GHQ, General Health Questionnaire; GIPCI, Global Impressions of Parent–child
Interactions; IY, Incredible Years; ODD, oppositional defiant disorder; PARI, Preschool ADHD Risk Index; PIP, Parenting Intervention Project; SNAP-IV-P, Swanson,
Nolan and Pelham Version 4 parent version; SNAP-IV-T, Swanson, Nolan and Pelham Version 4 teacher version; TAU, treatment as usual; WAI-S, Working Alliance
Inventory, Short Form; WWP, Werry-Weiss-Peters Activity Rating Scale.
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participating in the trial, the sample will be characterized
using a number of factors that have been associated with
such families. These factors will include: socioeconomic
status; education; employment; number and age of siblings
residing in the home; ethnicity; single parent status; age of
parent at time of birth; parental mental health problems
or ADHD; child language and communication problems
and the presence of other child comorbid conditions.
Informed consent
In the 10-week period prior to the start of each parent-
ing programme tranche, two research fellows in each
area will have responsibility for obtaining written in-
formed consent to administer screening and diagnostic
measures to parents, usually at their homes or some other
convenient location or, if necessary, by phone. Standard
informed consent procedures will be followed both for the
administration of screen and diagnostic interview mea-
sures and, if the parent is eligible and willing, for partici-
pation in the full study. If the parent is not eligible, the
parent will be informed and this will be confirmed in writ-
ing to the parent and the parent’s clinician or practitioner
where appropriate. If the measures indicate that (1) all in-
clusion criteria have been met and (2) that in the event of
being allocated to IY, the parent would be available toattend an IY programme on a fixed day in a local centre
or hall where crèche facilities will be made available, the
parent and child will be eligible for inclusion in the full
study. A screen and diagnostic interview case report form
(CRF) will be completed by the research fellow, indicating
that all inclusion criteria were met together with the par-
ent or main caregiver scores for all completed measures.
If the parent is willing to participate, the research fellow
will arrange to visit the parent’s home. At the T1 visit,
written informed consent to participate in the full study
will be obtained and T1 measures will be collected. Protocol
assessments will be performed according to the schedule
in Table 1. After consent is obtained and the visit has been
completed, a T1 CRF will be completed by the research
fellow to record the measures completed at the visit and
the scores for these measures.
The research administrator will then liaise with the
UoSCTU to complete the process of randomization and
the participant will be randomized to an arm of the study.
General practitioners will be informed of the parent’s par-
ticipation both at the start and end of the study. All partic-
ipants will be informed that they can withdraw from the
study at any time without their rights being affected. In
the case where consent to treatment is withdrawn but the
participant agrees to remain in the research study, the par-
ticipant will be followed to completion.
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After consent has been received, the participant will be
randomized into an arm of the study by the UoSCTU
using the online TENALEA system [67]. Randomization
procedures will be carried out prior to the start of each
parenting programme tranche and will take place during
normal working hours (Monday to Friday, 9 a.m. to
5 p.m.). Only the trial co-ordinator (DMC) and designated
research administrator staff at each centre will be respon-
sible for liaising with the UoSCTU in randomizing partici-
pants. When possible and to help maintain blindness,
groups of eight or more participants within each centre
will be randomized together. Upon receipt of an electronic
file from each centre, designed by the UoSCTU to provide
participant IDs and initials, centre attended and other
details necessary for TENALEA system randomization,
the UoSCTU will carry out randomization. Parents will
be block randomized to adapted-NFPP, IY or TAU arms
in the ratio 3:3:1. Automated email confirmation of
randomization will be sent to the authorized individual
at each centre. Details of the randomization will then be
added to the screen and diagnostic interview CRF by
the research administrator. A copy of this CRF, together
with the T1 CRF, will be checked and verified by the
centre principal investigator and sent by courier or, in
the case of the Southampton centre, delivered by hand
to the UoSCTU, along with a copy of all measures col-
lected at these two visits. Data measures will be gathered
and CRFs completed and processed in a similar manner at
T2 and T3 visits.
Participants in each centre will be informed by desig-
nated research staff as to which arm of the study they have
been allocated and this will be confirmed in writing. In the
case of parents randomized to the TAU group, parents will
be offered a place on a parenting programme in the com-
munity to commence approximately 4 weeks after T2 data
collection, which will be ‘end of study’ for TAU partici-
pants. Those participants allocated to adapted-NFPP and
IY will also be asked to complete T3 measures 6 months
after treatment. Research fellows will remain blind to treat-
ment allocation. Research fellows will inform the partici-
pant when arranging home visits at T2 and T3 data
collection that this blindness should be maintained on their
visit. Any breaches of blindness will be recorded. The
screen and diagnostic interview CRF containing allocation
details will be filed separately from other documents con-
tained in participant files to which the research fellows will
have access, as will all other such documents.
Data collection methods
Data collection will take place at the parent’s home at
each of the three time points. All research fellows will
have a degree in psychology and will be trained in the
administration of all measures. The majority of measuresare self-completed (on paper) by the parent, as indicated
in Table 1. A description of study instruments are out-
lined below together with details of reliability and valid-
ity, where available.
Screen and diagnostic interview
Werry-Weiss-Peters activity rating scale (WWP: [45])
The WWP is a 27-item parent-completed questionnaire
measuring hyperactivity. This has been shown to identify
the top 15 to 18% of the population using a score of 20
as a cut-off [68]. Psychometric properties have been
reviewed by Barkley [69], who reported discrimination be-
tween hyperactive and normally developing children to be
good. The interparent agreement has also been found to
be good (r = 0.82) [70]. The WWP is easy to complete and
has been shown to have high levels of internal consistency,
to correlate with other measures of hyperactivity and to
identify children who have activity problems 5 years
later [71].
Diagnostic interview schedule for children – version
4 (DISC-IV - ADHD Scale [46]) If a score of 20 or more
is reported on the WWP, the DISC-IV will be adminis-
tered to the parent or main caregiver. The DISC-IV uses
criteria contained in the DSM-IV and enquires about
hyperactive and inattentive symptoms and impairment
in both home and school settings. The standard DISC-
IV impairment algorithm requires moderate impairment
in at least one area of functioning related to ADHD symp-
toms, as judged by parental responses. Impairment on the
DISC is defined by the degree to which the symptoms
have (a) caused distress to the child; (b) affected relations
with caregivers, family, friends or teachers; or (c) affected
school functioning. The DISC has been shown to have
moderate to substantial test-retest reliability and internal
consistencies. Training in administration and scoring of
this measure was overseen by the clinical lead (MT), the
trial co-ordinator and other researchers with extensive ex-
perience in its administration.
Parent Involvement Project (PIP) developmental scales
[47] If DISC-IV inclusion criteria are met, the PIP devel-
opmental scales will be administered by the research
fellow. This developmental checklist is widely used by
educational psychologists as either an interview schedule
with the parents or an observation schedule. It gives a
profile of the child in five different areas: physical develop-
ment, social development, eye-hand co-ordination devel-
opment, development of play and language development.
The chart also suggests the age that children will normally
develop these skills and has age norms up to age 4 years.
In this study, it will be used as an interview schedule with
the mother and it will give an indication of any possible
developmental delay. An educational psychologist was
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ing in the administration of this measure by the research
fellow was carried out by the clinical lead (MT).
Outcome measures
SNAP-IV parent (SNAP-IV-P: 56]) and teacher scales
(SNAP-IV-T: 56]) The self-completed SNAP-IV-Parent
ADHD Scale is the primary outcome measure in this trial
with the teacher-completed SNAP-IV-T ADHD Scale and
the SNAP-IV-P and T ODD Scale used as secondary out-
come measures. The Multimodal Treatment Study of
Children with ADHD (MTA) version of the SNAP-IV is
used in this trial [72]. The 26 items include 18 ADHD
symptoms (nine inattentive, nine hyperactive or impul-
sive) and 8 ODD symptoms, as specified in the DSM-IV.
Items are rated for frequency by the parent or teacher on
a 4-point scale (0 = not at all to 3 = very much) and aver-
age ratings per item are then calculated for each subscale.
Bussing et al. [56] examined the psychometric properties
of the SNAP-IV-P and found that the internal consistency
for overall parent ratings was 0.94 (inattentive 0.90; hyper-
active or impulsive 0.79, ODD 0.89). Internal consistency
for the SNAP-IV-T was 0.97 (inattentive 0.96, hyperactive
or impulsive 0.92, ODD 0.96). Interrater reliability be-
tween parent and teacher ratings was 0.49 for inattention,
0.43 for hyperactivity or impulsivity and 0.47 for ODD
and all were statistically significant (P < 0.001).
Eyberg child behaviour inventory (ECBI: [57]) The
ECBI is a parent-completed 36-item inventory for the
assessment of problem behaviours in children aged 2 to
16 years. It includes a seven-point intensity scale (never
to always) that measures the frequency of each problem
behaviour and a yes-no problem scale that identifies
whether the behaviour is currently seen as a problem.
The ECBI can be used both as a clinical screening meas-
ure for identifying and treating externalizing problems in
children and as a measure of treatment outcome. Cut-offs
representing high-risk children are 127 for the problem
scale and 11 for the intensity scale. The ECBI has been
shown to correlate well with independent observations of
children’s behaviours and can differentiate between clinic-
referred and nonclinical populations. Reliability coefficients
for the ECBI scales range from 0.86 (test-retest) to 0.98 (in-
ternal consistency) [57,73].
Child’s solo play [27] This independent observation
measure, which is carried out by the research fellow dur-
ing 5 minutes of solo child play with a standard activity
toy, is an important secondary outcome measure. The
‘Little People Animal Sounds Zoo’ is a multipurpose toy
that includes a number of different activity zones (for
example, water slides, a ticket office and a tree cave).
Patterns of attending to and switching from one activityto another during independent play are measured and
an index of attention or engagement is calculated (time
on task divided by total number of switches from zone
to zone). High index scores represent more attention and
less switching. This measure has high test-retest reliability
(Pearson r = 0.81) and interrater reliability (Pearson r =
0.76) and good validity, differentiating, as it does, children
with ADHD from those without. Research fellows are
trained in the administration and scoring of solo play by
one of the principal investigators (DD), who has exten-
sive experience in the development and scoring of this
measure.
Revised client service receipt inventory (CSRI-R: 58])
The CSRI-R allows the collection and combining of
health economic data in a retrospective format from a
range of different sources using a range of different ap-
proaches (interview, health records, and so on). In this
study, a 3-month recall window or ‘since the last CSRI’
will be used for the interview section. The interview sec-
tion conducted by the research fellow asks about the
parental background and whether the child’s behaviour
has affected career prospects and has had an impact on
the finances of the family. There is also a section on use
of services, including any major service use at any point
in the young person’s life. The CSRI has good face validity
[58] and test-retest reliability and has been used in several
evaluations of care for children with needs related to men-
tal health. Instruction in the completion of this measure
will be given by experienced health economists.
EQ-5D [59] The EuroQol or EQ-5D is a standardized
questionnaire for use as a measure of health outcome.
The EQ-5D-3 L (five dimensions, three levels) used in
this study consists of the descriptive system and the EQ-
5D visual analogue scale (EQ-5D VAS). The descriptive
system comprises five dimensions: mobility, self-care,
usual activities, pain or discomfort and anxiety or de-
pression. Each dimension has three levels, no problems,
some problems and extreme problems, and the respond-
ent is asked to tick the box against the most appropriate
statement in each of the five dimensions. The VAS records
the respondent’s self-rated health on a vertical, visual
analogue scale (0 to 100) with endpoints representing the
worst and best imaginable health states. Both the self-
completed parent- and proxy-parent-reported child mea-
sures are used in this trial. This is a generic measure,
applicable to a wide range of health conditions and can be
used in the clinical and economic evaluation of health
care. The parent-completed measure is widely used and
has shown moderate levels of validity. The parent-proxy
measure has not been sufficiently validated, particularly
with younger children. However, Matza and colleagues
[74] have looked at the parent-proxy ratings of children
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able to detect impairment in these children. The index
and the VAS also showed significant correlations with
ADHD symptoms using DSM-IV criteria for ADHD.
Matza et al. concluded that parent-proxy ratings are feas-
ible and valid for use as part of an overall health outcomes
assessment in clinical studies of childhood ADHD [74].
Mediators
The following measures allow investigation of the possible
role of positive and constructive parenting and scaffolding,
improved maternal mental health and improved inhibition
with greater delay tolerance by the child in mediating the
impact and effectiveness of the parenting intervention.
Expressed emotion (EE): five-minute preschool speech
sample (FMSS: [60]) The parent is asked to speak for
exactly 5 minutes about his or her child, his or her feelings
and thoughts about the child, and how they get along to-
gether. The parent is to use his or her own words without
any interruptions from the interviewer. The parent’s re-
sponse is taped. Parental EE is rated on the initial state-
ment, warmth, emotional overinvolvement, relationship,
positive and critical comments. A coding manual is used
for the FMSS. An overall score can be given for the level
of EE with a high level indicating a negative influence. The
measure has shown acceptable code-recode and interrater
reliability and adequate test-retest reliability. It also dem-
onstrated to have acceptable validity, being associated with
less affection and greater maternal direction during play
interaction, and discriminating between the parents of
preschool children with symptoms of ADHD and those
without such symptoms [60]. Training of research fellows
in the administration and scoring of the FMSS will be
overseen by the author of this measure (DD).
Global impressions of parent–child interactions -
revised (GIPCI-R: [61,62]) This measure involves the
direct observation of mother-child interactions while
completing three tasks, each of 5 minutes’ duration:
‘jigsaw’, ‘free play’ and ‘tidy-up’. The 15 minutes of par-
ent–child interaction are videotaped and coded at a later
time using the GIPCI coding manual. Child items rated
are: respect, destruction, disruptive, noncompliance, so-
cial skills, valence and disconnection. Parent items rated
are valence, responsiveness, warmth, praise, enjoyment,
scaffolding, effectiveness, aggression and criticism or pun-
ishment. The measure generates summary global ratings
(1 to 5) for both parent and child behaviours with a higher
score indicating a more positive outcome. Thompson
et al. [26] found adequate interrater reliability for child
scores across all item codes (0.62; range 0.48 to 0.77) and
for parent scores (0.64; range 0.48 to 0.79). There was also
good internal consistency for child and parent scales (0.84;0.87). Test-retest reliability was adequate for the parent
measure (r = 0.50) but low for the child measure (r = 0.20).
Training in administration and scoring will be carried out
by the clinical lead in the trial (MT).
Delay of gratification: cookie delay task [63] This task
involves placing an edible treat under one of three
upturned transparent cups and asking the child to wait
for a signal before retrieving the treat. Eight trials are
given in a pseudorandom order with delays of between 5
and 30 seconds. The scoring is 0 = not inhibited, 1 = par-
tially inhibited and 2 = fully inhibited, giving a possible
range of scores 0 to 16. The task has been shown to be
reliable and to discriminate between hard-to-manage
preschoolers and their peers [75].
General health questionnaire (GHQ: [64]) The parent-
completed GHQ was developed as a screening instru-
ment for use in primary care settings to identify those
likely to have or be at risk of developing psychiatric dis-
orders. It is a measure of common mental health prob-
lems, such as depression, anxiety, somatic symptoms
and social withdrawal. This trial employs the 12-item ver-
sion of the GHQ, which has been shown to be consistent
and reliable across time. Items are scored from 0 to 3, with
a total score ranging from 0 to 36, where a lower score in-
dicates health and a higher score indicates illness. This
measure is widely used and has shown adequate reliability
and validity over a number of studies.
Moderators
The possible moderating role of high-risk factors, in-
cluding the presence of maternal ADHD symptoms, and
other indicators of poor outcome and long-term high
burden will be investigated. Measures will also be used
to monitor process and treatment fidelity across both
parenting programmes.
Current symptoms scale (CSS: 67] The CSS is an 18-
item questionnaire designed to assess ADHD symptoms
in adults and is based on the DSM-IV definition of
symptoms of ADHD. The CSS self-report scale requires
adults to rate the frequency of their own symptoms over
the previous 6 months on a 4-point scale ranging from 0
(rarely) to 3 (very often). A score of nine symptoms or
more experienced as ‘often’ or ‘very often’ is used as the
standard cut-off to identify adults at risk of clinical prob-
lems of ADHD. The scale has been shown to be correlated
with spousal, parental and cohabiting partner ratings of
symptoms. It comes with a manual for hand scoring,
has age- and sex-specific norms and has good psycho-
metric properties, including acceptable levels of internal
consistency and excellent test-retest reliability.
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the projects in the 5-year Programme for Detection and
Early Intervention for ADHD is to develop the PARI, a
way to identify preschool children with ADHD most at
risk of poor outcome and high burden. This is based on
a prospective follow-up of a large sample of individuals
who were identified as having symptoms of ADHD at a
preschool age in the 1990s but are now entering late
adolescence or early adult life. The risk index is derived
from a statistical process involving (i) identification of
those children with high levels of ADHD symptoms at
3 years who fall into high- and low-burden groups and
(ii) the use of logistic regression to model child, parental
and socioeconomic predictors of poor outcome and high
burden in the sample of children. Ten parameters will
be included in the model: initial ADHD symptom levels;
socio-emotional problems; temperament; language delay;
developmental delay; maternal mental health; maternal
age; parental marital status; perinatal risk and social
class. This information will be obtained from a number
of sources, including birth and patient records, a demo-
graphic questionnaire and the current trial measures (for
example, maternal mental health). The temperament
measures will be taken using the EASI scale, a 10-item
scale measuring emotionality (five items) and shyness
(five items), giving a score out of 5 for each subscale
[76]. The index so developed and used in the current
study will include the significant predictors of high bur-
den weighted in relation to the strength of their contri-
bution to the regression model. The final form taken by
the index which will be used will be based on data col-
lected from the ongoing PARI study and is not currently
known at present.
Leader Observation Tool (LOT: [53]) Process fidelity
will be measured using a modified version of the LOT
after treatment is finished. This revised version is adapted
from the LOT tool used to successfully monitor the fidelity
of the IY, which is delivered to parents in a group format.
Random sessions from the videotaped IY and adapted-
NFPP therapy sessions will be observed and coded by an
independent observer, who will score adherence to content
week by week as well as the process by which the
programme is delivered. The LOT has high internal reli-
ability and good code-recode and interrater reliability.
Evidence of concurrent validity has also been obtained.
Working alliance inventory, short form: parent and
therapist versions (WAI-S: [54]) The WAI-S is a
12-item self-report measure of working alliance. The
working alliance is an important part of the process of
therapy, and looks at the alliance of task, goals and rela-
tionship of therapist with parent and vice versa. Most
studies suggest that this alliance is usually forged within2 to 4 weeks of the beginning of therapy. Two versions
of the WAI-S are available: a client version and a therap-
ist version. In this trial, both versions will be completed
by the parent and therapist in weeks 6 and 12 of the par-
enting programme with each form being treated as con-
fidential and delivered to the research office in a sealed
envelope by the therapist. The authors of this measure
found a correlation with outcome. The WAI-S has three
subscales: goals, tasks and bond. Each subscale is scored
on a 7-point Likert-type scale ranging from 1 (never) to
7 (always) and has four nonoverlapping items. Subscale
scores can range from 4 to 28, to produce a total score
of 12 to 84 with higher scores reflecting more positive
ratings of working alliance. Internal consistency estimates
of the three subscale scores, based on an initial validation
sample of 124 pairs of parents and their therapists, ranged
from 0.90 to 0.92 (client version) and 0.83 to 0.91. Internal
consistency estimates of the total scores were 0.98 (parent
version) and 0.95 (therapist version [54].
Family Strain Index (FSI: [55]) Impact of treatment on
the family will be measured using the FSI questionnaire
at the start and end of the parenting programme. This six-
item questionnaire is designed to measure two primary
aspects of stress and demand on parents and families, spe-
cifically, the ‘emotional’, and ‘restrictiveness’ experiences
of living with a child with ADHD. Parents will be asked to
rate the frequency of occurrence of each of six items over
the past 4 weeks on a 5-point scale scored 0 (never) to 4
(always) with a total score in the range 0 to 24. This meas-
ure will be used at baseline and at the end of therapy.
The measure has been shown to have excellent in-
ternal consistency across the six items (Cronbach’s α =
0.83 to 0.87) and for the full scale (Cronbach’s α = 0.87).
Statistical analysis
The main analyses will be performed using the intention-
to-treat population. All results will be reported according
to the CONSORT statement for nonpharmacological in-
terventions [66]. The primary endpoint for the compari-
son between adapted-NFPP and IY will be the average
ADHD score on items 1 to 18 of the SNAP-IV-P at post-
treatment. The primary analysis of this endpoint will ad-
just for baseline SNAP-IV-P scores using a mixed-effect
regression model [77] with treatment arm and time (pre-
and post-treatment) as the fixed effects and therapist as
a random effect. Subject to approval, this analysis will
also include trial centre and recruitment tranche as
randomization stratification factors. These models are
especially valuable when used with longitudinal and trial
data derived from parallel arms. A similar secondary
analysis comparing adapted-NFPP and IY will be carried
out 6 months after treatment. Secondary outcome mea-
sures, including the Child’s Solo Play Index, ECBI
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with SNAP-IV-P ODD scores, will be analyzed in the
same way as SNAP-IV-P ADHD.
Subject to approval, a per-protocol analysis will also be
performed. The parent will be considered to have com-
pleted the parenting programme if he or she had com-
pleted at least 8 of the 12 programme sessions. In the
case of the IY programme, this will be either by attend-
ing the group or by receiving individual home-based ses-
sions for any missed sessions.
Therapist effects
Four or more therapists (depending on numbers re-
cruited) will work in each of the three study centres with
two therapists working on each intervention. The mixed
effects regression models will include therapist as ran-
dom effects within these models, allowing for the extent
to which treatment effects differ between therapists and
also accounting for the way in which participants are
nested by therapist. Even when the difference between
treatment effects can be assumed to be identical for all
therapists, the mixed model can improve the precision
of the treatment estimates by taking appropriate account
of the different therapists in the analysis.
Missing data
Drop-out in this trial is defined as noncompletion of mea-
sures at the end of the 12-week parenting programmes. A
drop-out rate of 10% has been estimated and the rates of
drop-out across the three arms will be compared using
analysis of variance. The randomness of missing data
resulting from drop-out will be explored across treatment
arms and, if random, standard mixed-effect regression
model procedures will be employed. If data loss is not ran-
dom, the modelling strategy will be based on Yang and
Shoptaw [78], which involves imputation of nonignorable
missing data due to drop-out using different models. The
effect of using several different models will be compared
to estimate imputed values. This method allows an explor-
ation of the range of possible effects of missingness and
provides the most conservative estimate of treatment ef-
fects, taking into account missing data due to drop-outs.
Mediational analysis
Exploratory mediational analysis will examine the extent
to which changes in ADHD symptoms are determined
by the effects of the treatment package on parents (more
positive and constructive parenting or improved mater-
nal mental health) and on children (improved inhibition
and greater delay tolerance). Analysis will be conducted
using regression approaches, as recommended by Valeri
and Vanderweele in their 2013 paper [79] using SAS and
SPSS; and path analysis using AMOS (for Windows) and
Mplus (Muthen & Muthen, Los Angeles, CA.).Moderator analysis
The presence of parental ADHD will be assessed using
the CSS [65]. This score will be collected at baseline and
an interaction term (CSS * treatment group) will be in-
cluded in the mixed-effect regression models to deter-
mine whether parent training might be less beneficial
for children whose parents demonstrate symptoms of
ADHD. The interaction term will be considered signifi-
cant for P < 0.05.
Risk of long-term burden as assessed by the PARI will
be included in the mixed-effect regression models to de-
termine whether this measure moderates the effect of
treatment on primary and secondary outcomes.
Genetic moderation of parent-training effects
DNA will be collected from parents and children, to test
whether parental responses to parent training in terms
of changes in parenting behaviour and the parent’s re-
sponses to the child during interaction are moderated by
functional polymorphisms in selected genes shown to
affect parenting and ‘openness’. These will include poly-
morphisms that have been associated with the ADHD
phenotype in genes that control serotonin, dopamine
and oxytocin function (DRD4; DRD2; 5HTT- group) will
be included in the mixed-effect regression models to de-
termine whether this measure moderates the effect of
treatment on primary and secondary outcomes.
Effects as a function of treatment fidelity
Scores from the LOT and the Working Alliance Inventory
will be used to calculate a fidelity composite measure
(scored 1 to 3, indicating low to high fidelity). An inter-
action term ‘fidelity composite score * treatment group’
and, similarly, an interaction term ‘FSI * treatment group’
will be included in the mixed-effect regression models to
determine whether these measures moderate the effect of
treatment on primary and secondary outcomes.
Health economic analysis
The economic analysis, adherent to guidelines for good
economic evaluation practices [80], will adopt a societal
perspective, including health and social services, as well
as any costs borne by families. The primary economic
evaluation will be in the form of cost-effectiveness ana-
lysis (CEA), and a secondary economic evaluation in the
form of cost-utility analysis (CUA). These will be based
on intention to treat and if approved, per-protocol ana-
lyses (see Statistical Analyses above).
Resource use and family borne costs
Detailed information on all resources required to pro-
vide both the adapted-NFPP and the IY programme will
be collected. This will include the design of a time col-
lection form to record therapist time spent providing the
McCann et al. Trials 2014, 15:142 Page 14 of 21
http://www.trialsjournal.com/content/15/1/142intervention inclusive of preparation and travel time. It
will also include resources such as manuals and hand-
outs, training and supervision and any necessary fidelity
procedures. Resource use will be combined with relevant
unit cost data to provide estimates of the costs of pro-
viding these interventions. The detailed breakdown of
the types of costs required will allow carrying out sensitiv-
ity analysis of the effect of varying any aspect of how the
interventions are provided. It will also allow comparison
of the economics of different modes of provision.
Patient-reported resource-use measures are an import-
ant component and one of the most challenging parts of
an economic evaluation. The CSRI [58] is considered
one of few resource-use measures that have been com-
prehensively tested and the validity and reliability of the
instrument is considered good, with consistency gener-
ally fairly well demonstrated [81]. An adapted version of
the CSRI will be used to collect detailed information
from all parents indicating contacts with frontline pro-
fessionals or specialized services and will allow identifi-
cation of ADHD related health and social care resource
use required by individuals and families. This will include
costs related to counselling services and support groups,
child education and day care, as well as employment re-
lated costs due to child’s health/behaviour. There is no
doubt that there is a tension between demand for infor-
mation on costs and its supply; this comprehensive cost
data collection will provide the opportunity to report on
economic implications of ADHD in preschool children.
Primary outcome measure and health-related quality of life
The preference-based generic health-related quality-of-life
(HRQoL) instruments enable comparisons across chronic
conditions and benchmarking with healthy population
samples. The economic evaluation alongside clinical trials
framework also enables estimation of quality-adjusted life
years (QALYs) and presentation of results in a cost per
QALY context. There is some doubt as to how appropriate
HRQoL scores will be in very young children. Given this,
it is not yet possible to identify the best paediatric generic
HRQoL instrument to be used in the preschool age group.
There is a paucity of research on the use of preference-
based measures of HRQoL such as the EQ-5D in very
young children. However, there is evidence supporting the
use of parent-proxy EQ-5D ratings of children with
ADHD in the UK and US. Matza et al. [75] assessed the
HRQoL of children with ADHD using the parents’ proxy
version of the EQ-5D and reported that the instrument
was able to detect impairment in children diagnosed with
ADHD and that this measure was feasible and valid when
used as part of an overall health outcomes assessment in
clinical studies of childhood ADHD. Hence, the within-
trial cost-effectiveness will be estimated using the EQ-5D
to estimate QALYs (CUA).Given the degree of change based on EQ-5D scores
compared with the primary outcome measure (SNAP-
IV-P), the effectiveness of this instrument in estimating
HRQoL to be used in economic evaluations alongside
clinical trials, for this age group, with ADHD symptoms,
will also be investigated.
Following NICE recommendations [67], as part of the
diagnostic process for children, there should also be an as-
sessment of their parents’ or carers’ mental health; in this
study, EQ-5D and EQ-5D VAS scores will be used to de-
tect changes on HRQoL for both (a) the child, using proxy
completion by the parent or main caregiver, and (b) the
parent’s or main caregiver’s own state of health.
Cost-effectiveness analysis (CEA)
The aim of the CEA will be to determine whether the
adapted-NFPP, a home-based parenting programme, is
more cost-effective with children at high risk of poor
outcomes than either a TAU group or a generic package
(IY: active control).
In addition to cost per QALY (CUA), the within-trial
CEA will also be estimated using the primary outcome
measure SNAP-IV-P, looking at cost per unit change in
the SNAP-IV-P score, to allow for the possibility that the
EQ-5D is not sensitive to changes in ADHD symptoms.
The NICE [67] reviewed treatments for ADHD, and,
in their economic evaluation, people with ADHD were
either classified as responders or nonresponders, based
on the Clinical Global Impression-Improvement (CGI-I)
Scale. A study from Lloyd et al. [82] developed a classifi-
cation system of four health states (normal; borderline
to mildly ill; moderately to markedly ill and severely ill),
reflecting different levels of severity of the patient’s symp-
toms. A similar approach will be explored, classifying
children by severity using the primary outcome and the
EQ-5D, depending on the variation in severity of those re-
cruited. In addition, by mapping the severity scale to the
improvement scale, the response to treatment will be esti-
mated, to allow classification of children as responders or
nonresponders, as described by NICE. Given that the
adapted-NFPP has recently been adapted to address the
specific needs of ‘hard-to-reach’ and ‘difficult-to-treat’
children, this analysis is appropriate. The results will be
presented as point estimates and cost-effectiveness accept-
ability curves. Deterministic sensitivity analysis will be
combined with probabilistic sensitivity analysis, to explore
different types of uncertainty.
Missing data will be examined as to whether cases
with missing data are similar to those with full economic
data in a similar manner to the main trial analysis. If cases
with missing data are similar to those with complete data,
an analysis will be carried out using only cases with
complete data (complete case analysis). If this is not the
case, appropriate measures of imputing missing data, for
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be done in consultation with the trial statistician. If results
using imputed values are produced, these will be in
addition to those using a complete case analysis.Ethical approval
The study protocol was approved by the National Re-
search Ethics Service, NRES Committee South Central
for Portsmouth and the University of Southampton.
The trial is registered with Current Controlled Trials
(ISRCTN39288126).Discussion
The COPPI trial will provide vital information about the
clinical value of parenting programmes for the treatment
of ADHD in preschool children and will provide novel
insights at a number of levels. For example, first, by con-
trasting a specialist intervention designed specifically to
target core ADHD symptoms (adapted-NFPP) against a
more generic parenting approach (IY), the trial is designed
to answer questions about the specificity of effects of par-
enting programmes within this sample. Second, by adding
a health economic component, the trial will be able to es-
tablish the value of any trade-off between the potentially
greater costs of a home-based one-to-one intervention
(adapted-NFPP) and a possibly less expensive group-based
alternative. Third, by studying a sample enriched for hard-
to-reach and difficult-to-treat families and preschool
ADHD children, this trial will allow us to test whether
programmes previously seen as effective with less challen-
ging samples can also work with clinically more complex
cases. Fourth, by taking direct observation measures along
with parent and teacher ratings, it will allow us to disen-
tangle the effects of rater (parent versus teachers versus
observer) from those of setting (home versus school).
Fifth, by testing for the mediating role of neuropsycho-
logical factors and altered parenting the trial will allow
the examination of the processes that drive therapeutic
change. Sixth, by collecting DNA and genotyping for
ADHD risk and more general susceptibility genes, the
study will allow us to isolate genetic factors that might
determine clinical response and help to better target
treatments in the future.
Attention-deficit/hyperactivity disorder is a major health
burden across the life span. Effective and cost-effective
treatments need to be developed and validated for use
with a range of different sorts of children with ADHD.
Early intervention, it has been argued, offers a number
of advantages, especially in optimizing the value of non-
pharmacological approaches. Establishing the value of
the COPPI interventions will present a major step for-
ward in the search for an effective early intervention
strategy for ADHD.Trial status
COPPI is an ongoing trial and it is expected that partici-
pant recruitment will continue, subject to approval, until
January 2014, when a final tranche of 12 week parenting
programmes will commence.Appendix 1
Adapted New Forest Parenting Programme (adapted-NFPP)
The New Forest Parenting Programme (NFPP)
This programme is centred around four broad themes:
1. The importance of psychoeducation; that the parent
understands preschool-type ADHD problems, and
therefore why the child may behave the way he or
she does.
2. The parent–child interaction and how that might be
enhanced.
3. Behavioural strategies that are targeted to the child
and the child’s symptoms.
4. The neuropsychological deficits for children with
ADHD, so work is done with the parent using
attention training games (to work on auditory
memory and visual memory) and helping the child
cope with delay and waiting as well as self-
organization.
Emphasis is also placed on scaffolding the parent to
be the child’s trainer, so that, in turn, the parent can
scaffold the child and work from the child’s level of de-
velopment. The parent is encouraged to practise tasks
outside the home and to use teachable moments to con-
solidate the learning. The importance of the therapist
using material brought by the parents (diaries, discus-
sion in sessions) to brainstorm strategies and the use of
modelling and role play as techniques for the therapist
is also emphasized. For some sessions, the child will also
be present.Brief summary of the timetable for parent training
The 12-week programme expands the time to deliver
the programme from an 8-week programme, so that the
programme can be delivered at a slower pace over the
12 weeks. To this programme, information has also been
added about: children with sleep disorder; parents with
a mental illness; parents with ADHD; parents with
learning difficulties; children with learning difficulties or
speech and language problems. The use of mindfulness
and social stories has also been added. Further informa-
tion has also been added in relation to motivational
techniques and the use of social stories. Each week, the
parent fills in a positive diary, a negative diary and, from
Week 3, a play diary. The parent is given handouts after
each session.
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The therapist delivering this new version will make an
introductory visit to the family to introduce the programme
and to assist in motivating the family. At this session, the
therapist will explain how the programme will be delivered
and arrange mutually convenient times for visits.Week 1
Parent alone Interview the parent to learn about this
particular child’s problems and symptoms; to understand
the child’s developmental history, to check for develop-
mental delay, including speech and language issues; to
learn more about the parents, their mental health, their
level of education, and to understand any other factors
that might be relevant to helping the parent and therapist
work together.
Discuss characteristics of ADHD, acceptance of child,
effectiveness of simple interventions. Emphasize import-
ance of praise and the use of simple language. Introduce
behaviour diary. The parent is given a diary to record
positive and negative moments at home and how these
were handled by the parent.Week 2
Parent alone Reinforce message from Week 1. Look at
diary and discuss parent’s feelings about behaviour dur-
ing week. Start discussing the effectiveness of simple in-
terventions, recruiting attention, listening skills and eye
contact. Emphasize importance of praise, of clear mes-
sages and short sentences, and the importance of clear
boundaries.
Discuss practising techniques; teachable moments; at-
tention training; impulsivity; the use of games. Give out
diaries and a play diary to record how the play with
games has gone.Week 3
Parent alone Reinforce messages from previous weeks.
Examine diaries and discuss parent’s feelings. Introduce
the concept of scaffolding. Discuss temper tantrums;
emphasize firmness and voice control and keeping calm
and focused; avoiding confrontation; the power of dis-
traction; mirror images; the importance of routine and
clear boundaries; countdowns. Play: introduce two new
games.Week 4
Parent and child Reinforce messages from previous
weeks and ensure that they have been implemented. Intro-
duce concepts of ‘I’ messages; ‘we’ messages; enthusiastic
tone of voice; speaking respectfully; use of choices and
house rules. Play.Week 5
Parent and child Review Weeks 1 to 4, focusing on
problems identified and solutions given. Assess parent’s
ability to implement strategies. Review diaries, isolate ex-
amples, and discuss how parents cope; reinforce psy-
choeducation; discuss teachable moments; observing
own child and planning ahead; attention training; dis-
traction techniques; quiet time; time out; behaviour
modification; speech and language development; par-
ent–child relationship and mindfulness. Play.
Week 6
Parent and child Consolidate the strategies and go over
the ones with which the parents are having difficulty,
using the diaries for material. Reinforce psychoeduca-
tion; attention training principles via play; teachable
moments; speech and language development; behaviour
modification; discussion and holding of parents, in
order to explore parental mental health and emotions;
stress positive interaction between mother and child by
using video interaction techniques.
Week 7
Parent alone Give feedback to the parent of the play
session carried out in the previous week. Underline the
importance of behavioural techniques discussed and
learned and illustrate with examples from the previous
weeks. Reinforce psychoeducation; holding of parents
through change; stress positive interaction between
mother and child by showing her the video; stress the
importance of speech and language and development
through play, through looking at books, nursery rhymes
and social stories.
Week 8
Parent alone Reinforce messages from previous weeks.
Focus on one or two of the key areas of particular con-
cern for each parent. Diaries should continue to be used
to identify these key areas and to provide examples of
good practice. Discuss how parent feels about continuing
with the strategies. Reinforce psychoeducation; discussion
and holding of parents in order to explore parental mental
health and emotions; review the use of social stories; recap
strategies. Review use of play.
Week 9
Parent and child Reinforce psychoeducation; review the
use of social stories; recap strategies; play session with
parent and child.
Week 10
Parent and child Reinforce psychoeducation; discussion
about what is relevant to parent; review the use of social
stories; recap strategies; play session with child.
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Parent alone Reinforce psychoeducation; discussion
about what is relevant to parent; review the use of social
stories; recap strategies; positive feedback and praise to
parent with viewing of previous week’s DVD. Endings: dis-
cussion that next week is last meeting.
Week 12
Parent alone Reinforce psychoeducation; discussion about
what is relevant to parent; review the use of social stories;
recap strategies; positive feedback and praise to parent;
endings; reinforce positive ways of problem-solving to cope
with future difficult situations; discuss importance of con-
tinuing ‘playtime’ in preparation for school and friends;
planning ahead (support network, encourage parents to
keep diary to track progress) and praise the parents.
The parent will be reminded that the psychologist will
be contacting the parent again within the next 2 weeks,
to arrange a short visit to the parent’s home, at a time
convenient to the parent, to carry out an interview for
the purpose of completing assessments and administer-
ing questionnaires.
The parent will also be reminded during this visit that
the psychologist will make contact again after 6 months
has elapsed (from the date of completion of the parent-
ing programme) to make arrangements for a similar
short visit to the parent to carry out a further interview
for the purpose of completing assessments and adminis-
tering questionnaires. At the end of this visit, the re-
search fellow will provide the parent with a debriefing
letter.
Appendix 2
Incredible Years (IY) 12-week parenting programme
12 weekly sessions will cover the goals in the order
outlined below.
Child-directed play promotes positive relationships
 Understanding the value of showing attention and
appreciation as a way of increasing positive child
behaviours;
 Understanding the importance of showing joy with
the child through songs and games;
 Understanding how to promote imaginary and
pretend play;
 Learning how to be child-directed and understanding
its value for children;
 Learning how to end play successfully with the
child;
 Learning about the child’s developmental needs and
milestones;
 Learning about the ‘modelling’ principle;
 Balancing power between parent and child; Building the child’s self-esteem and creativity
through child-directed play;
 Understanding the ‘attention rule’.
Promoting language with child-directed coaching
 Understanding how to model and prompt language
development;
 Learning how to coach preschool readiness skills;
 Learning about ‘descriptive commenting’ and
child-directed coaching;
 Learning about ‘persistence coaching’ to build the
child’s ability to be focused and calm and to persist
with an activity;
 Learning about the ‘modelling principle’;
 Understanding how to promote prereading and
prewriting readiness skills;
 Appreciating normal differences in the child’s
developmental abilities and temperament; completing
temperament checklist.
Social and emotion coaching
 Understanding how to use emotion coaching to build
the child’s emotional vocabulary and encourage
self-expression of feelings;
 Understanding how to prompt social coaching to
encourage the child’s social skills such as sharing,
being respectful, waiting, asking, taking turns;
 Learning the ‘modelling principle’, by the parent
avoiding the use of critical statements and demands
and substituting positive polite language, the child
learns more positive communication;
 Understanding how to coach sibling and peer play
using modelling, prompting and praise to encourage
social skills;
 Understanding developmental stages of play;
 Learning how to apply coaching principles in other
settings such as mealtimes, bath time and grocery
store trips.
The art of praise and encouragement
 Labelling praise ‘Give to get’ principle, for adults and
children;
 Attending to learning ‘process’, not only end results;
 Modelling self-praise;
 Resistance to praise, the difficulties in giving and
accepting praise;
 Promoting positive self-talk;
 Using specific versus nonspecific encouraging
statements;
 Gaining and giving support through praise;
 Avoiding praising only perfection;
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need praise;
 Building the child’s self-esteem through praise and
encouragement.
Spontaneous incentives for children
 Shaping behaviours in the direction you want, ‘small
steps’;
 Clearly identifying positive behaviour;
 Rewards are a temporary measure leading to the
child learning a new behaviour;
 What will reinforce one child will not necessarily
reinforce another;
 Value of unexpected and spontaneous rewards;
 Recognizing the ‘first-then’ principle;
 Designing programmes that are realistic and
developmentally appropriate;
 Understanding how to set up programmes for
problems such as not dressing, noncompliance,
picky eating, difficulty going to bed, toilet training
and rough animal care;
 Importance of reinforcing oneself, teachers, and others.
Handling separations and reunions
 Establishing clear and predictable routines for
separating from the child;
 Establishing routines for greeting the child after
being away from them;
 Understanding object and person permanence;
 Providing adequate monitoring at all times;
 Understanding how peek-a-boo games help children;
 Understanding how predictable routines for bedtime
and schedules help the child feel secure and safe;
 Completing the child-proof home safety checklist.
Positive discipline; effective limit setting
 Reduce number of commands to only necessary
commands;
 Learning about the importance of distractions and
redirections;
 Understanding the value of giving the child some
choice;
 Politeness principle and modelling respect;
 Clear and predictable household rules offer children
safety and reduce misbehaviours;
 ‘Monitoring principle’: understanding the
importance of constant monitoring and supervision
for toddlers;
 All children will test rules, don’t take it personally;
 Commands should be clear, brief, respectful, and
action-oriented; ‘When-then’ commands can be effective;
 Distractible children need warnings and reminders.
Positive discipline; handling misbehaviour
 Understanding how to use distractions and
redirections coupled with ignore;
 Parents maintaining self-control using calm-down
strategies and positive self-talk;
 Repeated learning trials, negative behaviour is a
signal child needs some new learning;
 Using the ignore technique consistently and
appropriately for selected behaviours, such as whining,
tantrums;
 Knowing how to help children practice calming
down;
 Know how to handle children who hit or bite;
 Understanding the importance of parents finding
support.
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